|
Europe's Pharmaceutical Industry |
An Innovation Profile. This paper maps the recent innovation record
of the European pharmaceutical industry vis-à-vis its US and
Japanese counterparts. August 1998 |
|
|
Gearing up for a global gravity shift - growth, risk and learning in
the Asia pharmaceutical market |
Asia pharmaceutical industry is gearing up to be at the centre of
the global market and most pharmaceutical companies in the region
expect this shift to happen fast. PwC report. 2007 |
|
|
Industry Information |
PwC-site on the Industry, surveys, articles and other information |
|
|
Life sciences strategic deal-making trends |
Successful alliances or partnerships can provide operational,
financial, and strategic benefits to each party. Mergers and
acquisitions also are an increasingly attractive option for both
biotechnology and pharmaceutical companies. October 2006 |
|
|
Marketing Strategies Work By Different Pharmaceutical Companies - A
Review |
This article will present the changing marketing strategies when a
pharma company shift from Acute base to Chronic therapy base. This
research paper will also give an insight about shift in supply chain
process and customer and end-customer perception which is the base
of formulation of different marketing strategies. |
|
|
Putting Benchmarking into Pharmaceutical Practice |
New Benchmarking models are not necessarily the way to superior
performance |
|
|
Rewriting the rules - Are today's integrated business models right
for tomorrow? |
The report questions the historic logic of in-house versus
in-licensed products when related to new cash and value
perspectives, questioning the one-model-fits-all blockbuster
business design. Pdf-file 0.2 MB, 2003 |
|
|
The
Euro and Pharmaceutical Pricing in Europe |
|
|
|
The
European pharmaceutical industry: Delivering sales excellence in
turbulent times |
A roadmap for getting the basics right and exploring the future.
This study highlights the challenges and opportunities that arise
from recent developments. It gives pharmaceutical companies a
platform from which to review their own sales models. |
|
|
The
Global Pharmaceutical Industry |
The case looks at the development of the ethical pharmaceutical
industry. The various forces affecting the discovery, development,
production, distribution and marketing of prescription drugs are
discussed in terms of their origins and recent developments. Readers
are then invited to consider trends for the future. pdf-file 2004 |
|
|
Thinking Beyond the Next Blockbuster |
Once the envy of other industries, pharmaceutical companies now face
mounting pressure and challenges that cannot be solved with
time-honored strategies or proven formulas. To succeed in this new
marketplace, Big Pharma could learn a thing or two from other
industry shake-ups.
|
|
|
US
Prescriptions |
List of the Top 200 US Prescriptions |
|
|
Where are the next profit zones in pharmaceuticals? |
Mercer research indicates that not all pharmaceutical firms will
continue to be successful using the `blockbuster' profit model,
given the constraints inherent in several fields of competition that
are starting to change the landscape. Instead, players must start
crafting far more differentiated strategies. pdf file |
|
